Objective voice changes in nondysphonic Parkinson's disease patients

Journal of Otolaryngology

Volumn 35, Issue 5, 2006, Pages 349-354

  Oguz, Haldun ^a,b   Tunc, Tugba ^a   Safak, Mustafa Asim ^a   Inan, Levent ^a   Kargin, Selda ^a   Demirci, Munir ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b SB Ankara Egitim Hastanesi   (Turkey)

Author keywords

Parkinson; Praat; Voice analysis

Indexed keywords

ACOUSTICS; ADULT; ARTICLE; CONTROLLED STUDY; DYSPHONIA; FEMALE; HUMAN; LARYNX DISORDER; LOUDNESS; NOISE; PARKINSON DISEASE; PRIORITY JOURNAL; VOICE; VOICE CHANGE;

AGED; FEMALE; HUMANS; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; VOICE;

EID: 33751249015     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2005.0130     Document Type: Article

References (15)

1. Ramig LO. Lee Silverman voice treatment for individuals with neurological disorders: Parkinson's disease. In: Stemple JC, editor. Voice therapy: clinical studies. San Diego (CA): Singular; 2000. p. 76-81.
2. Titze IR. Workshop on acoustic voice analysis: summary statement. Iowa City (IA): National Center for Voice and Speech; 1995.
3. Wolfe V, Martin D. Acoustic correlates of dysphonia: type and severity. J Commun Disord 1997;30:403-15.
4. Praat manual. Version 4.2.17. Amsterdam: Phonetic Sciences Department, University of Amsterdam, the Netherlands, 2005.
5. MDVP manual. Version 2.7.0. Lincoln Park (NJ): Kay Elemetrics Corporation; 2005.
6. Reijonen P, Soderlund SL, Rihkanen H. Results of fascial augmentation in unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol 2002;111:523-9.
7. Kandogan T, Seifert E. Influence of aging and sex on voice parameters in patients with unilateral vocal paralysis. Laryngoscope 2005;115:655-60.
8. Morsomme D, Jamart J, Wery C, et al. Comparison between the GIRBAS scale and the acoustic and aerodynamic measures provided by EVA for the assessment of dysphonia following unilateral vocal fold paralysis. Folia Phoniatr Logop 2001;53:317-25.
9. Colton RH, Casper JK. Extrapyramidal disorders. In: Understanding voice disorders: a physiological perspective for diagnosis and treatment., Baltimore (MD): Williams & Wilkins; 1996. p. 120-6.
10. Holmes RJ, Oates JM, Phyland DJ, et al. Voice characteristics in the progression of Parkinson's disease. Int J Lang Commun Disord 2000;35:407-18.
11. Blumin JH, Pcolinsky DE, Atkins JP. Laryngeal findings in advanced Parkinson's disease. Ann Otol Rhinol Laryngol 2004;113:253-8.
12. Logemann JA, Fisher HB, Boshes B, et al. Frequency and coocurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord 1978;43:47-57.
13. Zwirner P, Murry T, Woodson GE. Phonatory function of neurologically impaired patients. J Commun Disord 1991;24:287-300.
14. Ramig LO, Countryman S, Thompson L, et al. Comparison of two forms of intensive speech treatment for Parkinson disease. J Speech Hear Res 1995;38:1232-51.
15. Gamboa J, Jimenez FJJ, Nieto A, et al. Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs. J Voice 1997;11:314-20.